Moderator: Kosh Agarwal

• Interferon as a Component of HBV Cure in 2024 and 2034  Harry Janssen
• Oral Presentation: IMMUNE SIGNATURE ASSOCIATED WITH VIRAL SUPPRESSION FOLLOWING NUCLEOS(T)IDE ANOLOGUE TREATMENT IN ADULTS LIVING WITH CHRONIC HBV INFECTION IN SOUTH AFRICA Marion Delphin
• Oral Presentation: SIMILAR RATES OF BIOCHEMICAL RESPONSE ARE OBSERVED ACROSS VIROLOGIC RESPONSE CATEGORIES OVER 96 WEEKS OF BULEVIRTIDE Pietro Lampertico
• Oral Presentation: FACTORS INFLUENCING HEPATITIS B SPECIALITY CARE REFERRAL AMONG REFUGEES RECENTLY RESETTLED TO THE UNITED STATES Erin Mann
• Oral Presentation: CHALLENGES AND OPPORTUNITIES FOR REENGAGING DIAGNOSED BUT UNTREATED HBV/HCV-INFECTED INDIVIDUALS IN THE UNITED STATES TO CARE (PRELIMINARY RESULTS FROM A MULTI-CENTER RELINK PROGRAM) Helen Nde
• Q&A